Abstract
：Objective To explore theefficacy and safety of 980 nm diode laser therapy for treatment of benign prostatichyperplasia (BPH). Methods Data of 170 patients with BPH treated with 980nm diode lasersystem were reviewed. The mean operative time, blood loss, surgical complications, theinternational prostate symptom score (IPSS), bladder residual urine volume and flow ratechanges were collected and analyzed. Results One hundred and seventy cases were safeduring the perioperative period. The average operation time was (74 ± 11) min, surgicalremoval of prostate tissue mass of (54±12) g, blood loss (72±11) ml. There was no TURsyndrome occurred. 170 patients were followed up 2 to 24 months. The IPSS decreased frompreoperative 25.0±5.5 to 9.0±2.5. The maximum flow rate increased from preoperative (6.2±2.3)ml/sto post-operative (17.4±3.5) ml/s. The residual urine volume decreased from preoperative(210.0±25.6) ml to postoperative (25.2±4.6) ml. All the differences were statisticallysignificant (P＜0.05).Conclusion Transurethral vaporization of 980 nm diode laser could be a safe and effectivetreatment modality for BPH. Key words: Prostatic hyperplasia; Laser surgery
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
